Literature DB >> 27123144

TPX2 in human clear cell renal carcinoma: Expression, function and prognostic significance.

Q I Chen1, Bin Cao1, Ning Nan1, Y U Wang1, X U Zhai1, Youfang Li1, Tie Chong1.   

Abstract

Targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a microtubule-associated protein. TPX2 is considered to be an important gene in tumorigenesis; however, the particular function of TPX2 in the development of human renal cell carcinoma (RCC) is unknown. In the present study, the expression, function and prognostic significance of TPX2 in human RCC was analyzed. A total of 286 tissue samples from patients with RCC who had undergone nephrectomies were utilized. Subsequently, the expression of TPX2 protein was investigated using immunohistochemistry and western blotting, and TPX2 mRNA expression was examined using reverse transcription-quantitative polymerase chain reaction. To establish the effect of TPX2 on the proliferation and invasion of the RCC cells, TPX2 expression was increased by stable transfection with a TPX2 vector and TPX2 expression was decreased using small interfering RNA. Proliferation of the RCC cells was analyzed using a WST-1 assay and an animal xenograft model with BALB/c nude mice, whilst invasion of the RCC cells was examined using a Matrigel-coated invasion chamber. It was demonstrated that TPX2 expression was significantly higher in the RCC tissues compared with normal kidney tissues (P<0.05). Furthermore, TPX2 expression was associated with tumor size, histological grade and tumor stage (P<0.05), and was observed to markedly increase the proliferation and invasion of the RCC cells. It may be concluded that the expression of TPX2 is significantly upregulated in RCC tissue, subsequently increasing the proliferative and invasive ability of RCC cells. Therefore, the protein may serve as a therapeutic target and independent prognostic factor in the treatment of human RCC.

Entities:  

Keywords:  prognosis; renal cell carcinoma; targeting protein for Xenopus kinesin-like protein 2

Year:  2016        PMID: 27123144      PMCID: PMC4840997          DOI: 10.3892/ol.2016.4396

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

Review 1.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

2.  Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.

Authors:  Sung K Hong; Chang W Jeong; Ji H Park; Hyung S Kim; Cheol Kwak; Gheeyoung Choe; Hyeon H Kim; Sang E Lee
Journal:  BJU Int       Date:  2010-08-26       Impact factor: 5.588

3.  Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.

Authors:  Jing Leng; Chang Han; A Jake Demetris; George K Michalopoulos; Tong Wu
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

4.  Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma.

Authors:  Liang Yan; Shenglei Li; Changbao Xu; Xinghua Zhao; Bin Hao; Huixiang Li; Baoping Qiao
Journal:  Tumour Biol       Date:  2013-07-20

5.  Reassessment of the 1997 TNM classification system for renal cell carcinoma.

Authors:  James M Elmore; Keith T Kadesky; Kenneth S Koeneman; Arthur I Sagalowsky
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

6.  Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.

Authors:  Hideo Shigeishi; Shinichi Fujimoto; Misato Hiraoka; Shigehiro Ono; Masayuki Taki; Kouji Ohta; Koichiro Higashikawa; Nobuyuki Kamata
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

7.  Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma.

Authors:  Hong-Chun Liu; Yi Zhang; Xli-Lin Wang; Wang-Sen Qin; Yu-Han Liu; Lan Zhang; Chang-Lian Zhu
Journal:  Biomed Pharmacother       Date:  2013-05-14       Impact factor: 6.529

8.  Phosphorylation of p53 is regulated by TPX2-Aurora A in xenopus oocytes.

Authors:  Gaetan Pascreau; Frank Eckerdt; Andrea L Lewellyn; Claude Prigent; James L Maller
Journal:  J Biol Chem       Date:  2009-01-02       Impact factor: 5.157

9.  Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells.

Authors:  Christopher D Scharer; Noelani Laycock; Adeboye O Osunkoya; Sanjay Logani; John F McDonald; Benedict B Benigno; Carlos S Moreno
Journal:  J Transl Med       Date:  2008-12-11       Impact factor: 5.531

10.  RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.

Authors:  Katia Y Cáceres-Gorriti; Euridice Carmona; Véronique Barrès; Kurosh Rahimi; Isabelle J Létourneau; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more
  5 in total

1.  Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model.

Authors:  Bin Liu; Yu Xiao; Hao Li; Ai-Li Zhang; Ling-Bing Meng; Lu Feng; Zhi-Hong Zhao; Xiao-Chen Ni; Bo Fan; Xiao-Yu Zhang; Shi-Bin Zhao; Yi-Bo Liu
Journal:  Biomed Res Int       Date:  2020-06-15       Impact factor: 3.411

Review 2.  Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Shijie Wang; Yongyuan Chen; Ying Chai
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 3.  Prognostic and clinical value of Targeting protein for Xenopus kinesin-like protein 2 in patients with gastrointestinal tract cancers: A meta-analysis.

Authors:  Wanwei Liu; Jiwei Xu; Caiyun Zhang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

4.  Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.

Authors:  Jun Zou; Rui-Yan Huang; Fu-Neng Jiang; De-Xiong Chen; Cong Wang; Zhao-Dong Han; Yu-Xiang Liang; Wei-De Zhong
Journal:  Oncol Lett       Date:  2018-06-25       Impact factor: 2.967

5.  Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.

Authors:  Wenxia Ma; Bin Wang; Chen Wang; Yaping Zhang; Ziyue Wang; Dan Niu; Siyu Chen; Zhirong Zhang; Ningning Shen; Weixia Han; Xiaoqin Zhang; Rong Wei
Journal:  Cancer Cell Int       Date:  2019-09-11       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.